Scott T. Rottinghaus, Chief Medical Officer at ENANTA PHARMACEUTICALS INC (ENTA), sold 866 shares at $8.06 ($7K) on 2024-12-06, disclosed to the SEC on 2024-12-10.
Open-market sale of $7k ENTA by Chief Medical Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| Filing → |
| ENTA | SELL | 2023-12-06 | $5K | — | Filing → |